The spatial orientation of the binding interactions was imperative to develop a consensus probe design. From the pharmacophore work it is also found that caffeine is a promiscuous binder, as it has strong pi-stacking interactions with multiple proteins. Therefore it was decided that a flexible probe molecule, which will reorganise around mephedrone, could prevent caffeine binding due to steric effects obstructing the aromatic functionalities without hydrogen bonding occurring with the thiourea groups. 
PDB accession code
Ligand ID
Paracetamol 3NK2
L- Dopamine   Table S1 . The 9 protein-ligand complexes used to determine the consensus mephedrone binding pharmacophore. NMR Studies (see pages 5 to 18): 1 H-NMR titrations were carried out by preparing a 20.0 mM solution of molecular probe 2 or model compound 3 (1-benzyl-3-phenylthiourea) in acetone-d 6 (1.0 mL). A stock solution of the free-base form of the drugs was prepared in acetone-d 6 (1.0 mL). Aliquots of 2.5 µL (2.5 µL = 0.1 equivalence of drug to probe) were added, the sample tube was shaken to ensure mixing and the 1 H-NMR spectra were recorded after each addition. 
Preparation of benzylthiourea aniline (3) 3
Model compound 3 was prepared based upon literature conditions. Aniline (400 mg, 392 µL, 4.3 mmol) and benzylisothiocyanate (0.64 g, 568 µL, 4.3 mmol) were taken up in ethanol (30 mL) and refluxed for two hours. Upon the formation of a precipitate, the reaction was allowed to cool to room temperature and filtered. The product, a cream coloured solid, was dried under vacuum, which yielded 0.62 g (59% yield) of compound 3. See Table S3 for 1 H and 13 C-NMR assignments. (4)). 
Mass Spectrometry Studies
Samples were prepared in HPLC grade acetone at 0.5 mg⋅mL -1 . For analysis of the complexed sample, 10 equivalents of mephedrone freebase were added to a 0.5 mg⋅mL -1 solution of probe 2 in acetone. Formic acid (1% v/v) was added to each sample as an ionizing agent before injection. To ensure that a probe 2-drug adduct is not an artifact, deuterated water was added to the sample to show an increase in the mass due to the exchange of the labile protons. Data was acquired in both the positive and negative ion mode. Needle voltage was 5000 V, drying gas temperature was 300°C, and nebulizer pressure was 24.6 psi. 
Computational DFT Studies
Conformational search was carried out for probe 2 alone and the Probe 2-guest complexes using Hyperchem 8.10 and OPLS force field. 4 Five lowest energy unique structures/complexes were subjected to PM7 calculations using MOPAC2012. 5 The lowest energy complexes for each NPS with probe 2 was optimized at the DFT level using B3LYP 6-311++G(2d,2p) 6 basis set in Orca 7 (version 3.0.3), and that was followed by generating and optimizing alternative complexes for comparison, i.e. to ensure that the minimum conformation of both drugs was in fact achieved. The mephedrone and flephedrone were studied in their respective binding positions, i.e. mephedrone was positioned to bind to probe 2 outside of the binding pocket and vice versa. The interaction energy between probe 2 and guest was calculated using energies of respective most stable conformations according to the following:
where E complex , E free 2 and E free guest represents the total energy of the complex, the free optimized 2, and the free optimized guest energy, respectively.
Computational Electrostatic Diagrams
Each of the electrostatic surfaces were calculated using VegaZZ using the minimized conformations previously calculated in the DFT studies. 7 Solid gradient surfaces were applied based on a four colour gradient, where red denotes low electrostatic potential and blue high electrostatic potential. The marching cubes method was implemented for surface calculations, which is based on surface facet approximation. 
UV-Vis and Fluorescence Studies
A solution of probe 2, 2.5 х 10 -4 M, was prepared in HPLC grade acetone. An additional solution containing 0.01 M mephedrone freebase was prepared and aliquots of 25 µL (25 µL = 0.25 equivalence of mephedrone freebase to probe 2) were added, spectra was recorded after each addition. A solution of probe 2, 5 х 10 -6 M, was prepared in HPLC grade acetone. An additional solution containing 5 х 10 -6 M probe 2 and 2.5 х 10 -4 M mephedrone freebase was prepared and aliquots of 10 µL (10 µL = 0.1 equivalence of mephedrone freebase to probe 1) were added, spectra was recorded after each addition. Neat fluorescence titration involved adding the neat mephedrone and flephedrone free base in 5 µL aliquots and the emission spectra was recorded after each addition. The excitation wavelength was at 410 nm. 
Simulated Street Protocol Studies:
When found in street samples, mephedrone is found in combination with any number of cutting agents, the two most common being caffeine and benzocaine. 8 It has already been shown that caffeine and benzocaine do not bind to the sensor, but to ensure mephedrone can be detected in such mixtures a protocol was established to freebase mephedrone in the presence of benzocaine and caffeine.
Mephedrone hydrochloride, benzocaine and caffeine were combined in equal proportions and taken up in water. The mixture was filtered to remove the undissolved cutting agents; as caffeine is only sparingly soluble in water compared to benzocaine and mephedrone hydrochloride. The mephedrone freebase was liberated with ammonium hydroxide (pH~10) and extracted into diethyl ether. The organic layer was washed multiple times with water to ensure there were no residual anions present. The organic layer was dried over MgSO 4 and evaporated to dryness yielding a yellow oil with small amounts of white solid from the remaining cutting agents. The 1 H-NMR of the mixture shows that all the compounds are still present; however, larger proportions of mephedrone are present compared to the caffeine and benzocaine. NMR titration of probe 2 against the extracted street sample mixture shows that mephedrone is still binding in the presence of the caffeine and benzocaine. 
